Autolomous highlights FDA approval for a novel gene therapy
The agency authorized the first treatment targeting Glycogen Storage Disease Type Ia, significantly reducing patients' strict dietary requirements.
See the latest news and media coverage for Autolomous. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences software company
autolomous.comLast updated
In short: Autolomous advanced digital manufacturing partnerships and celebrated FDA gene therapy approvals
The agency authorized the first treatment targeting Glycogen Storage Disease Type Ia, significantly reducing patients' strict dietary requirements.
The company broadens its manufacturing management systems from cell and gene therapy to biopharma and life sciences. Announced May 6, 2026.
Kresladi treats children with severe Leukocyte Adhesion Deficiency Type I, a rare immune disorder. Autolomous celebrates this milestone for CGT sector.
Alexander Seyf talks with IBTV about the Digital Pioneer Program with Adva Biotechnology and GenCART for decentralized cell therapy manufacturing.
Charles River Laboratories International, Inc. (NYSE: CRL) and Autolomous today announced the launch of Apollo Orchestrate™, a new capability within Charles River's Apollo ® platform...
Adva Biotechnology Ltd. and Autolomous Ltd. announced the launch of the Digital PIONEER Program, a joint initiative aimed at digitizing, decentralizing, and scaling out autologous...
Autolomous, announces the market availability of autoloMATE Launchpad. This free, self-service platform enables teams of any resource level across CGT manufacturing to integrate digital planning...
Autolomous,, and BioCentriq, announce a collaboration to digitize and accelerate process development and manufacturing activities. Autolomous’ autoloMATE(R) solution is an innovative, no-code, fully cloud-native software...
Track Autolomous and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Autolomous and other trending companies.